Rémi is a seasoned scientist and R&D leader with 25+ years of experience in Biopharma/Biotech industry in Europe and North America. Based on his experience and passion for innovative medicines, he founded his consulting company, ImmThera Consulting SAS. Since then, he has been working for mature biotech, start-up, TTO, Biopharma, and CRO. Prior Immthera, he held the position of CSO at Genticel, a clinical stage Biotech focused on immunotherapy targeting oncogenic HPV. He had also developed an ADC at preclinical stage in solid tumors as CSO of Skymab Biotherapeutics. Prior his biotech experience, he led the development of innovative Biologics from discovery to late clinical stage at GSK for 18 years in the field of oncology and chronic disorders, eg. immune disorders. Through his career in R&D as well as during a brief time in commercial strategy in oncology at GSK, he developed a solid product vision and know-how in R&D of innovative drugs to move and translate discoveries into potential commercial assets.